X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs JUBILANT LIFE SCIENCES - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA JUBILANT LIFE SCIENCES ABBOTT INDIA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 39.4 18.6 211.1% View Chart
P/BV x 11.4 4.5 252.9% View Chart
Dividend Yield % 0.5 0.4 133.2%  

Financials

 ABBOTT INDIA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-17
JUBILANT LIFE SCIENCES
Mar-14
ABBOTT INDIA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs5,190187 2,778.4%   
Low Rs4,35165 6,683.6%   
Sales per share (Unadj.) Rs1,382.9364.3 379.6%  
Earnings per share (Unadj.) Rs130.26.8 1,901.7%  
Cash flow per share (Unadj.) Rs137.924.5 563.0%  
Dividends per share (Unadj.) Rs40.003.00 1,333.3%  
Dividend yield (eoy) %0.82.4 35.2%  
Book value per share (Unadj.) Rs652.7164.9 395.8%  
Shares outstanding (eoy) m21.25159.28 13.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.40.3 997.9%   
Avg P/E ratio x36.618.4 199.2%  
P/CF ratio (eoy) x34.65.1 672.8%  
Price / Book Value ratio x7.30.8 956.9%  
Dividend payout %30.743.8 70.1%   
Avg Mkt Cap Rs m101,37320,061 505.3%   
No. of employees `0003.16.2 49.8%   
Total wages/salary Rs m3,45311,052 31.2%   
Avg. sales/employee Rs Th9,531.99,383.0 101.6%   
Avg. wages/employee Rs Th1,119.91,786.9 62.7%   
Avg. net profit/employee Rs Th897.3176.3 509.0%   
INCOME DATA
Net Sales Rs m29,38758,034 50.6%  
Other income Rs m576191 302.4%   
Total revenues Rs m29,96358,224 51.5%   
Gross profit Rs m3,9735,786 68.7%  
Depreciation Rs m1642,812 5.8%   
Interest Rs m203,237 0.6%   
Profit before tax Rs m4,365-72 -6,054.0%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m1,598696 229.5%   
Profit after tax Rs m2,7671,090 253.7%  
Gross profit margin %13.510.0 135.6%  
Effective tax rate %36.6-965.9 -3.8%   
Net profit margin %9.41.9 501.0%  
BALANCE SHEET DATA
Current assets Rs m18,90629,280 64.6%   
Current liabilities Rs m6,29738,912 16.2%   
Net working cap to sales %42.9-16.6 -258.5%  
Current ratio x3.00.8 399.0%  
Inventory Days Days6284 73.7%  
Debtors Days Days2251 42.7%  
Net fixed assets Rs m1,15955,712 2.1%   
Share capital Rs m213155 137.5%   
"Free" reserves Rs m13,65720,968 65.1%   
Net worth Rs m13,86926,265 52.8%   
Long term debt Rs m017,169 0.0%   
Total assets Rs m20,63888,606 23.3%  
Interest coverage x215.01.0 21,986.3%   
Debt to equity ratio x00.7 0.0%  
Sales to assets ratio x1.40.7 217.4%   
Return on assets %13.54.9 276.5%  
Return on equity %19.94.2 480.5%  
Return on capital %31.611.6 273.4%  
Exports to sales %037.8 0.0%   
Imports to sales %016.5 0.0%   
Exports (fob) Rs mNA21,933 0.0%   
Imports (cif) Rs mNA9,567 0.0%   
Fx inflow Rs m022,004 0.0%   
Fx outflow Rs m011,749 0.0%   
Net fx Rs m010,255 0.0%   
CASH FLOW
From Operations Rs m3,0728,026 38.3%  
From Investments Rs m-1,554-1,744 89.1%  
From Financial Activity Rs m-898-4,447 20.2%  
Net Cashflow Rs m6211,834 33.8%  

Share Holding

Indian Promoters % 0.0 45.6 -  
Foreign collaborators % 75.0 3.5 2,142.9%  
Indian inst/Mut Fund % 7.9 8.7 90.8%  
FIIs % 0.1 21.2 0.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 21.1 81.0%  
Shareholders   18,270 23,815 76.7%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  ALEMBIC PHARMA  AJANTA PHARMA  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

ABBOTT INDIA at All Time High; BSE HEALTHCARE Index Down 0.7%

Jun 22, 2018 | Updated on Jun 22, 2018

ABBOTT INDIA share price has hit an all time high at Rs 7,420 (up 1.67%). The BSE HEALTHCARE Index is down by 0.74%. Among the top gainers in the BSE HEALTHCARE Index today are ABBOTT INDIA (up 1.67%) and GSK PHARMA (up 0.01%). The top losers include PFIZER (down 0.00%) and IPCA LABS (down 0.01%).

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jun 22, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - UNICHEM LAB COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS